Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2018

01-06-2018 | Health Services Research and Global Oncology

Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer

Authors: Shaila J. Merchant, MSc, MHSc, MD, FRCSC, FACS, Susan B. Brogly, PhD, Craig Goldie, MD, Christopher M. Booth, MD, Sulaiman Nanji, MD, PhD, Sunil V. Patel, MSc, MD, Katherine Lajkosz, MSc, Nancy N. Baxter, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2018

Login to get access

Abstract

Background

We examined the delivery of physician palliative care (PC) services and its association with aggressive end-of-life care (EOLC) in patients with gastrointestinal (GI) cancer in Ontario, Canada.

Methods

All patients with primary cause of death from esophageal, gastric, colon, and anorectal cancer from January 2003 to December 2013 were identified. PC services within 2 years of death were classified: (1) any PC; (2) timing of first PC (≤ 7, 8–90, 91–180, and 181–730 days before death); and (3) intensity of PC measured by number of days used (1st–25th, 26th–50th, 51st–75th, and 76th–100th percentiles). Aggressive EOLC was defined as any of the following: chemotherapy, emergency department visits, hospital or intensive care unit (ICU) admissions (all ≤ 30 days of death), and death in hospital and in the ICU; these were combined as a composite outcome (any aggressive EOLC).

Results

The cohort included 34,630 patients, of whom 74% had at least one PC service. Timing of the first PC service varied: ≤ 7 (12%), 8–90 (42%), 91–180 (16%), and 181–730 (30%) days before death. Compared with patients not receiving PC, any PC was associated with a reduction in any aggressive EOLC (risk ratio [RR] 0.75, 95% confidence interval [CI] 0.74–0.76); this association was similar regardless of timing of the first PC service. The most dramatic reduction in aggressive EOLC occurred in patients who received the greatest number of days of PC (RR 0.65, 95% CI 0.63–0.67).

Conclusions

The majority of patients received PC within 2 years of death. A larger number of days of PC was associated with a greater reduction in aggressive EOLC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ. 2016;188(10):E217-27.CrossRefPubMedPubMedCentral Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ. 2016;188(10):E217-27.CrossRefPubMedPubMedCentral
2.
go back to reference Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741-9.CrossRefPubMedPubMedCentral Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741-9.CrossRefPubMedPubMedCentral
3.
go back to reference Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial. J Clin Oncol. 2017;35(8):834-41.CrossRefPubMed Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial. J Clin Oncol. 2017;35(8):834-41.CrossRefPubMed
4.
go back to reference Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-42.CrossRefPubMed Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-42.CrossRefPubMed
5.
go back to reference Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-30.CrossRefPubMed Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-30.CrossRefPubMed
6.
go back to reference Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96-112.CrossRefPubMed Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96-112.CrossRefPubMed
7.
go back to reference Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F. European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5 year review of the Designated Centers’ incentive program. Ann Oncol. 2010;21(2):362-9.CrossRefPubMed Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F. European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5 year review of the Designated Centers’ incentive program. Ann Oncol. 2010;21(2):362-9.CrossRefPubMed
9.
go back to reference Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380-6.CrossRefPubMed Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380-6.CrossRefPubMed
10.
go back to reference Morita T, Akechi T, Ikenaga M, Kizawa Y, Kohara H, Mukaiyama T, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23(12):2637-44.CrossRefPubMed Morita T, Akechi T, Ikenaga M, Kizawa Y, Kohara H, Mukaiyama T, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23(12):2637-44.CrossRefPubMed
11.
go back to reference Osta BE, Palmer JL, Paraskevopoulos T, Pei BL, Roberts LE, Poulter VA, et al. Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med. 2008;11(1):51-7.CrossRefPubMed Osta BE, Palmer JL, Paraskevopoulos T, Pei BL, Roberts LE, Poulter VA, et al. Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med. 2008;11(1):51-7.CrossRefPubMed
12.
go back to reference Iwashyna TJ, Christakis NA. Attitude and self-reported practice regarding hospice referral in a national sample of internists. J Palliat Med. 1998;1(3):241-8.CrossRefPubMed Iwashyna TJ, Christakis NA. Attitude and self-reported practice regarding hospice referral in a national sample of internists. J Palliat Med. 1998;1(3):241-8.CrossRefPubMed
13.
go back to reference Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315-21.CrossRefPubMed Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315-21.CrossRefPubMed
14.
go back to reference Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587-91.CrossRefPubMedPubMedCentral Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587-91.CrossRefPubMedPubMedCentral
15.
go back to reference Hu W, Yasui Y, White J, Winget M. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006–2009. J Pain Symptom Manag. 2014;47(2):231-44.CrossRef Hu W, Yasui Y, White J, Winget M. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006–2009. J Pain Symptom Manag. 2014;47(2):231-44.CrossRef
16.
go back to reference Liu TW, Hung YN, Earle CC, Liu TP, Liu LN, Tang ST. Characteristics and correlates of increasing use of surgery in taiwanese cancer patients’ last month of life, 2001–2010. Ann Surg. 2016;264(2):283-90.CrossRefPubMed Liu TW, Hung YN, Earle CC, Liu TP, Liu LN, Tang ST. Characteristics and correlates of increasing use of surgery in taiwanese cancer patients’ last month of life, 2001–2010. Ann Surg. 2016;264(2):283-90.CrossRefPubMed
17.
go back to reference Warren JL, Barbera L, Bremner KE, Yabroff KR, Hoch JS, Barrett MJ, et al. End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst. 2011;103(11):853-62.CrossRefPubMedPubMedCentral Warren JL, Barbera L, Bremner KE, Yabroff KR, Hoch JS, Barrett MJ, et al. End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst. 2011;103(11):853-62.CrossRefPubMedPubMedCentral
19.
go back to reference Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, et al. Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA. 2016;315(3):272-83.CrossRefPubMed Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, et al. Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA. 2016;315(3):272-83.CrossRefPubMed
20.
go back to reference Dumont S, Jacobs P, Fassbender K, Anderson D, Turcotte V, Harel F. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective. Palliat Med. 2009;23(8):708-17.CrossRefPubMed Dumont S, Jacobs P, Fassbender K, Anderson D, Turcotte V, Harel F. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective. Palliat Med. 2009;23(8):708-17.CrossRefPubMed
21.
go back to reference Hung YN, Liu TW, Wen FH, Chou WC, Tang ST. Escalating health care expenditures in cancer decedents’ last year of life: a decade of evidence from a retrospective population-based cohort study in Taiwan. Oncologist. 2017;22(4):460-9.CrossRefPubMedPubMedCentral Hung YN, Liu TW, Wen FH, Chou WC, Tang ST. Escalating health care expenditures in cancer decedents’ last year of life: a decade of evidence from a retrospective population-based cohort study in Taiwan. Oncologist. 2017;22(4):460-9.CrossRefPubMedPubMedCentral
22.
go back to reference Merchant SJ, Lajkosz K, Brogly SB, Booth CM, Nanji S, Patel SV, et al. The final 30 days of life: a study of patients with gastrointestinal cancer in Ontario, Canada. J Palliat Care 2017 32:92-100.CrossRefPubMed Merchant SJ, Lajkosz K, Brogly SB, Booth CM, Nanji S, Patel SV, et al. The final 30 days of life: a study of patients with gastrointestinal cancer in Ontario, Canada. J Palliat Care 2017 32:92-100.CrossRefPubMed
23.
go back to reference Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SM (2015) Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst 107(3):dju424.CrossRefPubMed Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SM (2015) Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst 107(3):dju424.CrossRefPubMed
24.
go back to reference Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, et al. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer. J Oncol Pract. 2017;13(9):e760-e9.CrossRefPubMed Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, et al. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer. J Oncol Pract. 2017;13(9):e760-e9.CrossRefPubMed
25.
go back to reference Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;(95):246-57. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;(95):246-57.
26.
go back to reference Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495-501.CrossRefPubMed Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495-501.CrossRefPubMed
27.
go back to reference Barbera L, Hwee J, Klinger C, Jembere N, Seow H, Pereira J. Identification of the physician workforce providing palliative care in Ontario using administrative claims data. CMAJ Open. 2015;3(3):E292-8.CrossRefPubMedPubMedCentral Barbera L, Hwee J, Klinger C, Jembere N, Seow H, Pereira J. Identification of the physician workforce providing palliative care in Ontario using administrative claims data. CMAJ Open. 2015;3(3):E292-8.CrossRefPubMedPubMedCentral
28.
go back to reference Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26(23):3860-6.CrossRefPubMedPubMedCentral Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26(23):3860-6.CrossRefPubMedPubMedCentral
29.
go back to reference Leveridge MJ, Siemens DR, Mackillop WJ, Peng Y, Tannock IF, Berman DM, et al. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology 2015;85(4):791-8.CrossRefPubMed Leveridge MJ, Siemens DR, Mackillop WJ, Peng Y, Tannock IF, Berman DM, et al. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology 2015;85(4):791-8.CrossRefPubMed
30.
go back to reference Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 2011;49(10):932-9.CrossRefPubMedPubMedCentral Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 2011;49(10):932-9.CrossRefPubMedPubMedCentral
33.
go back to reference Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199-200.CrossRefPubMed Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199-200.CrossRefPubMed
34.
go back to reference Bascioni R, Giorgi F, Rastelli F, di Pietro Paolo M, Brugni M, Basirat F, et al. Impact of hospice and palliative home care on chemotherapy use at the end of life (EOL). J Clin Oncol. 2011;29(15 Suppl):e16611.CrossRef Bascioni R, Giorgi F, Rastelli F, di Pietro Paolo M, Brugni M, Basirat F, et al. Impact of hospice and palliative home care on chemotherapy use at the end of life (EOL). J Clin Oncol. 2011;29(15 Suppl):e16611.CrossRef
35.
go back to reference Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-45.CrossRefPubMedPubMedCentral Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-45.CrossRefPubMedPubMedCentral
36.
go back to reference Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94(10):2733-7.CrossRefPubMed Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94(10):2733-7.CrossRefPubMed
37.
go back to reference Flannery L, Ramjan LM, Peters K. End-of-life decisions in the Intensive Care Unit (ICU)—the experiences of ICU nurses and doctors: a critical literature review. Aust Crit Care. 2016;29(2):97-103.CrossRefPubMed Flannery L, Ramjan LM, Peters K. End-of-life decisions in the Intensive Care Unit (ICU)—the experiences of ICU nurses and doctors: a critical literature review. Aust Crit Care. 2016;29(2):97-103.CrossRefPubMed
Metadata
Title
Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer
Authors
Shaila J. Merchant, MSc, MHSc, MD, FRCSC, FACS
Susan B. Brogly, PhD
Craig Goldie, MD
Christopher M. Booth, MD
Sulaiman Nanji, MD, PhD
Sunil V. Patel, MSc, MD
Katherine Lajkosz, MSc
Nancy N. Baxter, MD, PhD
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6430-9

Other articles of this Issue 6/2018

Annals of Surgical Oncology 6/2018 Go to the issue